The overall incidence of adverse reactions and the types of adverse reactions seen were similar among men and women treated with NEURONTIN. The incidence of adverse reactions increased slightly with increasing age in patients treated with either NEURONTIN or placebo.
Risk Factors for Vitiligo. Vitiligo affects up to 2% of the population, and it is estimated that two to five million Americans have the condition. In most cases, vitiligo develops early in life, between the ages of 10 and 30 years. Ninety-five percent of those affected will develop the disorder before age 40.
vitiligo - an acquired skin disease characterized by patches of unpigmented skin (often surrounded by a heavily pigmented border) xanthoma - a skin problem marked by the development (on the eyelids and neck and back) of irregular yellow nodules; sometimes attributable to disturbances of cholesterol metabolism.